Virtual Workshop - Topical Drug Development - Evolution of Science and Regulatory Policy II
Thursday, July 23, 2020
Virtual Workshop via WebEx
FDA/M-CERSI Workshop: Topical Drug Development - Evolution of Science and Regulatory Policy
Two Day Event: July 23-24, 2020 from 8:30 a.m. to 5:30 p.m.
This workshop was previously scheduled for June 30, and was postponed to July 23-24, 2020. The meeting will still be conducted in a virtual format.
** This is a virtual workshop - information about participating via WebEx will also become available in the coming days. **
This workshop will highlight the advances in the recent assessment of dermal penetration using both in vivo, in vitro, and in silico models. It will be built upon the successful workshop sponsored by M-CERSI in July, 2019.
This workshop is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD005946 totaling $5,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.